 |
|
|
TRENDS IN MOLECULAR MEDICINE
|
|
|
|
|
|
|
 Former title: Molecular Medicine Today
Editor:
A. Romina Emilianus
See editorial board for all editors information
Description
Trends in Molecular Medicine's objective is to facilitate communication between groups of highly trained professionals with distinct backgrounds and skills, whose common goals are to understand and explain the molecular basis of disease with a view to new clinical practice. Trends in Molecular Medicine is a resource for students and professionals alike, who have information needs that transcend the traditional clinical or scientific categorisation.
Trends in Molecular Medicine includes review articles on the genetic basis of disease, but 'molecular' does not only mean DNA. The diagnostic role of genetic processes is clear, but major benefits in health and disease are also provided by other molecules: enzymes, antibiotics, hormones, metals, carbohydrates, lipids, vitamins, synthetic organic and inorganic polymers. Such benefits are discussed and evaluated by Trends in Molecular Medicine. Furthermore 'Medicine' involves a vital societal element; molecular intervention raises controversial ethical, legal and financial issues. All these issues are addressed in Trends in Molecular Medicine in a style that builds on 25 years' experience of publishing the Trends Journals.
Click here to access content from this title along with other Trends journals
Ethics in Publishing: General Statement
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.
For more information, please refer to:  http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest
|
Bibliographic details
|
ISSN: 1471-4914
Imprint: TRENDS
Commenced publication 1995
Subscriptions for the year 2009, Volume 15, 12 issues |
| Price and Ordering |
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Order access for 2009 now and get the rest of 2008 for FREE!
|
Personal price:
EUR 204 for European countries and Iran
USD 224 for all countries except Europe, Japan and Iran
JPY 24,800 for Japan
|
 |
Institutional price:
USD 1,719 for all countries except Europe, Japan and Iran
EUR 1,537 for European countries and Iran
JPY 213,300 for Japan
|
|
Conditions of sale & ordering procedures, and links to our regional sales offices.
|
For an overview of recently-dispatched issues, see the Journal issue dispatch dates
Audience
Medical students, graduate students in the biomedical sciences, all scientists (academic and industrial) and clinicians with an interest in understanding the molecular basis of disease and molecular biology to prevent, diagnose and treat disease.
Impact factor of this journal
2007: 7.244
© Journal Citation Reports 2008, published by Thomson Reuters
608/594
Last update: 20 Nov 2008
|
|
|
|
|
|
|
|
|
|
| For Editors |
|
|
|
Tracking for Editors
|
|
|
|
